Clinical study to assess an Ayurvedic combination as a tablet orally and as an ointment for external application in patients affected with Psoriasis
- Conditions
- Health Condition 1: null- Moderate to Severe PsoriasisHealth Condition 2: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2017/02/007812
- Lead Sponsor
- Clinfound Clinical Research Services Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
1.Patients with active, stable psoriasis defined by the following criteria:
a.DLQI > 10 at baseline
2.Patients who are willing to sign the informed consent form and agree to return to follow-up visits.
1.Patients who were making use of biologics, corticosteroids or nonsteroidal anti-inflammatory and non-steroid, or who made use of these topical medications until 15 days before inclusion or 30 days before inclusion when the administration was orally.
2.Patients with evidence of Skin conditions other than psoriasis.
3.Patients who also had psoriatic plaques of skin disorders caused by fungi or bacteria and they were making use of antibiotic or antifungal.
4.Patients using Psoralen plus ultraviolet radiation (PUVA), cyclosporine, alefacept, methotrexate, acitretin, or any other systemic anti-psoriasis therapy within 28 days of study drug initiation
5.Pregnant and/or nursing women
6.Patients using oral anticoagulants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method